United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ecolab healthcare division - glycerol; industrial methylated spirit - cutaneous gel - 10mg/1gram ; 700mg/1gram

Ireland - English - Ecolab

ecolab deutschland gmbh -

Ireland - English - Ecolab

ecolab deutschland gmbh -

Ireland - English - Ecolab

ecolab deutschland gmbh -

Australia - English - Department of Health (Therapeutic Goods Administration)

ecolab pty ltd - ethanol, quantity: 67.9685 % w/w - gel - excipient ingredients: trolamine; carbomer 940; purified water; glycerol - antiseptic handrub.

Ireland - English - HPRA (Health Products Regulatory Authority)

spirig pharma europe gmbh - 5-aminolevulinic acid hydrochloride - medicated plaster - 8 milligram

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - aspirin,clopidogrel hydrogen sulfate -

United States - English - NLM (National Library of Medicine)

american health packaging - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), dipyridamole (unii: 64alc7f90c) (dipyridamole - unii:64alc7f90c) - aspirin 25 mg - aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. aspirin and extended-release dipyridamole capsules are contraindicated in patients with known hypersensitivity to any of the product components. aspirin, usp is contraindicated in patients with known allergy to nonsteroidal anti-inflammatory drug (nsaid) products and in patients with the syndrome of asthma, rhinitis and nasal polyps. aspirin, usp may cause severe urticaria, angioedema or bronchospasm. do not use aspirin, usp in children or teenagers with viral infections because of the risk of reye syndrome. teratogenic effects, pregnancy category d. [see warnings and precautions (5.4)]. aspirin can result in excessive blood loss at delivery as well as prolonged gestation and prolonged labor. because of these effects on the mother and because of adverse fetal effects seen with aspirin during the later stages of pr

United States - English - NLM (National Library of Medicine)

bayer healthcare llc. - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e) - pain reliever - for the temporary relief of minor aches and pains or as recommended by your doctor - ask your doctor about other uses for bayer 81 mg orange chewable aspirin - if you are allergic to aspirin or any other pain reliever/fever reducer - this product for at least 7 days after tonsillectomy or oral surgery unless directed by a doctor - if you have ever had an allergic reaction to this product or any of its ingredients - an allergic reaction occurs. seek medical help right away. - you experience any of the following signs of stomach bleeding: - feel faint - vomit blood - have bloody or black stools - have stomach pain that does not get better - pain gets worse or lasts more than 10 days - redness or swelling is present - new symptoms occur - ringing in the ears or a loss of hearing occurs

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), dipyridamole (unii: 64alc7f90c) (dipyridamole - unii:64alc7f90c) - aspirin 25 mg - aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. aspirin and extended-release dipyridamole capsules are contraindicated in patients with known hypersensitivity to any of the product components. aspirin is contraindicated in patients with known allergy to nonsteroidal anti-inflammatory drug (nsaid) products and in patients with the syndrome of asthma, rhinitis, and nasal polyps. aspirin may cause severe urticaria, angioedema or bronchospasm. do not use aspirin in children or teenagers with viral infections because of the risk of reye syndrome. teratogenic effects , pregnancy category d. [see warnings and precautions (5.4) ]. aspirin can result in excessive blood loss at delivery as well as prolonged gestation and prolonged labor. because of these effects on the mother and because of adverse fetal effects seen with aspirin during the later stages of pregnancy [se